PML and cancer: Given the rarity of TICs in cancer-free PML samples and the difficulty of longitudinal monitoring, adjacent non-tumor tissues with known malignant outcomes, as well as mouse and organoid models of tumorigenesis, can serve as accessible surrogates for investigating longitudinal progression.